A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral ...

Covering a wide range of up-to-date and industry relevant technologies, you will become familiar with the latest advances and commercial techniques in molecular cell biology. This exciting Masters ...

According to an analysis of the video from the scene, which shows a powerful secondary detonation, this could, with a high probability, be the warehouse where the Kh-101 and Kh-555 cruise missiles ...

"It's much like doing a medical CT scan where you can see inside of the cell non-destructively, so you don't have to cut the cell open," says Carolyn Larabell, a cell biologist at UC San Francisco.

Engineers turn skin cells directly into neurons for cell therapy Date: March 13, 2025 Source: Massachusetts Institute of Technology Summary: Researchers devised a process to convert a skin cell ...

ARC101 is the company’s first bispecific antibody targeting Claudin 6 (CLDN6), optimized for best-in-class T cell engagement -- First-in-human study will evaluate the safety, tolerability, ...

Single-cell transcriptomics has revolutionized the study of cellular diversity and function by enabling gene expression analysis at single-cell resolution. The technique is crucial for ...

today announced the trial design for the expansion of its THIO-101 pivotal Phase 2 trial in non-small cell lung cancer (NSCLC). Following successful outcomes to date in THIO-101, the expansion of ...

(NYSE American: MAIA) ("MAIA," the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the trial design for the expansion of its THIO ...

KROS 101 addresses an Achilles' heel of all T cell immunotherapies and that is ... utilizing structural biology to overcome drug resistance and immune suppression in cancer. Our lead candidate ...